Report overview
Gastroesophageal Reflux?Disease (GERD) is a digestive disorder that occurs when acidic stomach juices, or food and fluids back up from the stomach into the esophagus.GERD?affects people of all ages?from infants to older adults. People with asthma are at higher risk of developing?GERD.
This report contains market size and forecasts of Gastroesophageal Reflux Drugs in global, including the following market information:
Global Gastroesophageal Reflux Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gastroesophageal Reflux Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Gastroesophageal Reflux Drugs companies in 2021 (%)
The global Gastroesophageal Reflux Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Esomeprazole Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastroesophageal Reflux Drugs include Bayer, Cadila Pharmaceuticals, AstraZeneca, Jiangsu Aosaikang, Eisai, Pfizer, Altana Pharma, Takeda and NCPC and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastroesophageal Reflux Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastroesophageal Reflux Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gastroesophageal Reflux Drugs Market Segment Percentages, by Type, 2021 (%)
Esomeprazole
Lansoprazole
Omeprazole
Rbeprazole
Dexlansoprazole
Others
Global Gastroesophageal Reflux Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gastroesophageal Reflux Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory surgical centers
Specialty clinics
Others
Global Gastroesophageal Reflux Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gastroesophageal Reflux Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastroesophageal Reflux Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gastroesophageal Reflux Drugs revenues share in global market, 2021 (%)
Key companies Gastroesophageal Reflux Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Gastroesophageal Reflux Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Cadila Pharmaceuticals
AstraZeneca
Jiangsu Aosaikang
Eisai
Pfizer
Altana Pharma
Takeda
NCPC
Luoxin
